Inflammatory bowel disease
Conditions
Interventions
Test group:None
Control group:None
Sponsors
West China Second University Hospital
Eligibility
Sex/Gender
All
Age
5 Years to 16 Years
Inclusion criteria
Inclusion criteria: Test group: 1) Children diagnosed with IBD for the first time, and the diagnosis of IBD conforms to the 2019 "Expert Consensus on the Diagnosis and Treatment of Inflammatory Bowel Disease in Children"; 2) Volunteer to participate and fill out an informed consent form. Control group: 1) Children with initial diagnosis of colon polyps and pathological confirmation of juvenile polyps; 2) No history of chronic gastrointestinal diseases or symptoms; 3) Voluntarily participate and provide informed consent.
Exclusion criteria
Exclusion criteria: Test group: 1) Those who have used antifungal drugs or fungal probiotics within the past 2 months; 2) Those who have used drugs related to the treatment of IBD; 3) Those who do not sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gene catalogue abundance analysis;alpha diversity analysis;KEGG analysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anosim analysis;Permutational multivariate analysis of variance; | — |
Countries
China
Contacts
Public ContactWang Zhiling
West China Second University Hospital
Outcome results
None listed